negative regulation of strand invasion

Any process that decreases the rate, frequency or extent of strand invasion. Strand invasion is the process in which the nucleoprotein complex (composed of the broken single-strand DNA and the recombinase) searches and identifies a region of homology in intact duplex DNA. The broken single-strand DNA displaces the like strand and forms Watson-Crick base pairs with its complement, forming a duplex in which each strand is from one of the two recombining DNA molecules.


negative regulation of termination of RNA polymerase II transcription

biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

Any process that stops, prevents or reduces the frequency, rate or extent of termination of RNA polymerase II transcription.


nitrogen catabolite repression of transcription

A transcription regulation process in which the presence of one nitrogen source leads to a decrease in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other nitrogen sources.


negative regulation of nucleotide catabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of nucleotides.


negative regulation of ribonuclease activity

Any process that decreases the rate, frequency, or extent of ribonuclease activity, catalysis of the hydrolysis of phosphodiester bonds in chains of RNA.


negative regulation of antisense RNA transcription

Any process that decreases the frequency, rate or extent of the synthesis of antisense RNA, an RNA molecule complementary in sequence to another RNA or DNA molecule, which, by binding the latter, acts to inhibit its function and/or completion of synthesis, on a template of DNA.


negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle

Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as part of the meiotic cell cycle.


negative regulation of double-strand break repair via break-induced replication

Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via break-induced replication.


negative regulation of base-excision repair

Any process that stops, prevents or reduces the frequency, rate or extent of base-excision repair.


suppression by virus of host mRNA processing

Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of mRNA processing in the host cell. mRNA processing is the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.


negative regulation of RNA polymerase III activity

Any process that stops, prevents or reduces the frequency, rate or extent of RNA polymerase III activity.


negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter in response to chemical stimulus

Any process that decreases the frequency, rate or extent of the synthesis of RNA from ribosomal protein genes by RNA polymerase II, originating at an RNA polymerase II promoter, as a result of a chemical stimulus.


carbon catabolite repression of transcription from RNA polymerase II promoter by galactose

Any process involving galactose that stops, prevents or reduces the rate of transcription from an RNA polymerase II promoter.


negative regulation of purine nucleobase metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving purine nucleobases.


transcription antitermination

A positive regulation of gene expression mechanism that allows RNA polymerase to continue transcription beyond a termination site, thus allowing expression of downstream genes under specific conditions.


carbon catabolite repression of transcription

A transcription regulation process in which the presence of one carbon source leads to a decrease in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other carbon sources. Carbon catabolite repression is a mechanism of genetic regulation which the accumulation of catabolites of one substance in the cell represses the formation of enzymes that contribute to the catabolism of other substances.


cadherin-13 isoform h4 (human)

A cadherin-13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55290-4.


cadherin-13 isoform h5 (human)

A cadherin-13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55290-5.


cadherin-13 isoform h1 (human)

A cadherin-13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55290-1.


cadherin-13 isoform h2 (human)

A cadherin-13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55290-2.


cadherin-13 isoform h3 (human)

A cadherin-13 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55290-3.


microtubule-associated protein tau isoform Tau-F phosphorylated 6 (human)

A microtubule-associated protein tau isoform Tau-F phosphorylated 6 in human. UniProtKB:P10636-8, Ser-416/Ser-422, MOD:00046|Thr-427, MOD:00047.


detection of salicylic acid stimulus

The series of events in which a salicylic acid stimulus is received by a cell and converted into a molecular signal.


cellular response to salicylic acid stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salicylic acid stimulus.


prostaglandin E2 receptor EP3 subtype isoform hEP3B (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-3.


prostanoid receptor

A rhodopsin-like G-protein coupled receptor that is a translation product of the human PTGDR, PTGDR2, PTGER1 to PTGER4, PTGFR, PTGIR, or TBXA2R genes, 1:1 orthologs thereof, or a semi-ortholog thereof. The active form binds prostanoids (prostaglandins and thromboxanes).


prostaglandin E2 receptor EP3 subtype isoform h12 (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-12.


prostaglandin F2-alpha receptor isoform h7 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-7.


prostaglandin D2 receptor isoform h2 (human)

A prostaglandin D2 receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13258-2.


prostaglandin F2-alpha receptor

A prostanoid receptor that is a translation product of the human PTGFR gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin F2a. This receptor is particularly prevalent in the corpus luteum, but is expressed in other tissues also.


prostaglandin D2 receptor isoform h1 (human)

A prostaglandin D2 receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13258-1.


prostaglandin F2-alpha receptor isoform h4 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-4.


prostaglandin E2 receptor EP3 subtype isoform hEP3-IV (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-9.


prostaglandin E2 receptor EP3 subtype isoform hEP3E2 (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-11.


prostaglandin E2 receptor EP3 subtype isoform hEP3E (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-5.


prostaglandin F2-alpha receptor isoform h3 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-3.


prostaglandin D2 receptor

A prostanoid receptor that is a translation product of the human PTGDR gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin D2 (PGD2). This receptor is found mainly in blood platelets, vascular smooth muscle, and nervous tissue. It is the least upiquitous of the prostanoid receptors, almost always occurring in association with other prostanoid receptor types.


prostaglandin E2 receptor EP2 subtype

A prostanoid receptor that is a translation product of the human PTGER2 gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin E2 (PGE2). This receptor is expressed mediates various effects, including relaxation of vascular smooth muscles, nonacid secretion from epithelial cells, inhibition of mediator release from mast cells and basophils, and activation of sensory afferent nerves.


prostaglandin E2 receptor EP3 subtype isoform hEP3A (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-1.


thromboxane A2 receptor

A prostanoid receptor that is a translation product of the human TBXA2R gene or a 1:1 ortholog thereof. The preferred ligand is thromboxane A2. This receptor is found mainly in vascular smooth muscle, where it mediates vasoconstriction, in platelets, where it mediates aggregation, and in airway smooth muscle.


thromboxane A2 receptor isoform h2 (human)

A thromboxane A2 receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P21731-2.


prostaglandin D2 receptor DP2

A prostanoid receptor that is a translation product of the human PTGDR2 gene or a 1:1 ortholog thereof. The preferred ligand is 11-dehydro-thromboxane B2. This receptor is not closely related to the prostaglandin D2 receptor encoded by PGD2.


prostaglandin E2 receptor EP1 subtype

A prostanoid receptor that is a translation product of the human PTGER1 gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin E2 (PGE2). This receptor has limited expression, although it is more evident in rodents than in other mammals.


prostacyclin receptor

A prostanoid receptor that is a translation product of the human PTGIR gene or a 1:1 ortholog thereof. The preferred ligand is prostacyclin (prostaglandin I2, PGI2). This receptor is widely distributed in blood platelets, vascular smooth muscle and nerve cells.


prostaglandin F2-alpha receptor isoform h1 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-1.


prostaglandin E2 receptor EP3 subtype isoform hEP3-V (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-10.


prostaglandin E2 receptor EP3 subtype isoform hEP3-III (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-8.


prostaglandin F2-alpha receptor isoform h6 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-6.


prostaglandin E2 receptor EP3 subtype isoform hEP3C (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-2.


prostaglandin E2 receptor EP3 subtype

A prostanoid receptor that is a translation product of the human PTGER3 gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin E2 (PGE2). This receptor is the most ubiquitous of the prostaglandin E2 receptors, mediating contraction of gastrointestinal, uterine, and vascular smooth muscle, inhibition of neurotransmitter release from autonomic nerves, inhibition of lipolysis in adipocytes, inhibition of acid secretion from gastric mucosa, and inhibition of water reabsorption in kidney.


prostaglandin E2 receptor EP3 subtype isoform hEP3G (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-7.


prostaglandin F2-alpha receptor isoform h5 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-5.


prostaglandin E2 receptor EP4 subtype

A prostanoid receptor that is a translation product of the human PTGER4 gene or a 1:1 ortholog thereof. The preferred ligand is prostaglandin E2. This receptor is not closely related to other prostaglandin E2 receptors.


prostaglandin E2 receptor EP3 subtype isoform hEP3D (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-4.


thromboxane A2 receptor isoform h1 (human)

A thromboxane A2 receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P21731-3.


prostaglandin E2 receptor EP3 subtype isoform hEP3F (human)

A prostaglandin E2 receptor EP3 subtype (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43115-6.


prostaglandin F2-alpha receptor isoform h2 (human)

A prostaglandin F2-alpha receptor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P43088-2.


alpha/beta hydrolase domain-containing protein 17A isoform 1 (human)

An alpha/beta hydrolase domain-containing protein 17A isoform 1 that is encoded in the genome of human.


osmosensory signaling MAPK cascade

biolink:Pathway biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:OntologyClass biolink:Occurrent biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

The series of molecular signals in which a stress-activated protein kinase (SAPK) cascade relays a signal, containing at least a Hog1/Sty1 family MAPK, a Pbs2/Wis1 family MAPKK and a Ssk2/Win1 family MAP3K.


osmosensory signaling via phosphorelay pathway

The series of molecular signals generated in response to osmotic change, as mediated through a phosphorelay system.


osmosensory signaling pathway via Sho1 osmosensor

The series of molecular signals generated in response to osmotic change, as mediated through a Sho1 osmosensor system.


coiled-coil domain-containing protein 17 isoform h3 (human)

A coiled-coil domain-containing protein 17 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96LX7-2.


homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform 1 (human)

A homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein isoform 1 that is encoded in the genome of human.


TOG array regulator of axonemal microtubules protein 2 isoform h1 (human)

A TOG array regulator of axonemal microtubules protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZUX3-1.


medulla oblongata formation

The process that gives rise to the medulla oblongata. This process pertains to the initial formation of a structure from unspecified parts. The medulla oblongata lies directly above the spinal cord and controls vital autonomic functions such as digestion, breathing and the control of heart rate.


afadin isoform h4 (human)

An afadin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55196-4.


metallothionein-1L acetylated 1 (human)

A metallothionein-1L that is N-terminal Met acetylated in human. UniProtKB:Q93083, Met-1, MOD:00058.


A protein that is a translation product of the human MT1L gene or a 1:1 ortholog thereof.


hyccin 2 isoform 1 (human)

A hyccin 2 isoform 1 that is encoded in the genome of human.


PDZ and LIM domain protein 3 isoform 2 (human)

A PDZ and LIM domain protein 3 isoform 2 that is encoded in the genome of human.


PDZ and LIM domain protein 3 isoform h1 (human)

A PDZ and LIM domain protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q53GG5-1.


PDZ and LIM domain protein 3 isoform h3 (human)

A PDZ and LIM domain protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q53GG5-3.


sodium/myo-inositol cotransporter 2 isoform h1 (human)

A sodium/myo-inositol cotransporter 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WWX8-1.


neurofascin isoform 9 (human)

A neurofascin isoform 9 that is encoded in the genome of human.


60S ribosomal protein L8 isoform 1 (human)

A 60S ribosomal protein L8 isoform 1 that is encoded in the genome of human.


protein-glutamine gamma-glutamyltransferase 6 isoform h1 (human)

A protein-glutamine gamma-glutamyltransferase 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95932-1.


protein-glutamine gamma-glutamyltransferase 6 isoform h2 (human)

A protein-glutamine gamma-glutamyltransferase 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95932-2.


negative regulation of response to benzene

Any process that stops, prevents or reduces the frequency, rate or extent of response to benzene.


regulation of response to benzene

Any process that modulates the frequency, rate or extent of response to benzene.


positive regulation of response to benzene

Any process that activates or increases the frequency, rate or extent of response to benzene.


calmodulin-activated 3',5'-cyclic-AMP phosphodiesterase activity

biolink:MolecularActivity biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

Catalysis of the reactions: nucleoside 3',5'-cyclic AMP + H2O = AMP + H+; this activity is activated by binding to calcium-bound calmodulin.


copine-9 isoform h2 (human)

A copine-9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IYJ1-2.


guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2, initiator methionine removed form (human)

A guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (human) that has had the initiator methionine removed. UniProtKB:P62879, 2-340.


chitobiose catabolic process

The chemical reactions and pathways resulting in the breakdown of any chitobiose, a family of compounds derived from chitin and based on the structure of D-glucosaminyl-(1->4)-D-glucosamine.


glycopeptide catabolic process

The chemical reactions and pathways resulting in the breakdown of glycopeptides, a compound in which carbohydrate is covalently attached to an oligopeptide composed of residues of L and/or D-amino acids. The term usually denotes a product of proteolytic degradation of a glycoprotein but includes glycated peptide.


amino sugar catabolic process

The chemical reactions and pathways resulting in the breakdown of any amino sugar, sugars containing an amino group in place of a hydroxyl group.


butirosin catabolic process

The chemical reactions and pathways resulting in the breakdown of butirosin.


anthocyanin-containing compound catabolic process

The chemical reactions and pathways resulting in the breakdown of anthocyanins, any member of a group of intensely colored soluble glycosides of anthocyanidins.


amino disaccharide catabolic process

The chemical reactions and pathways resulting in the breakdown of any amino disaccharide, a disaccharide having one or more substituted or unsubstituted amino groups in place of hydroxy groups at unspecified positions.


gentamycin catabolic process

The chemical reactions and pathways resulting in the breakdown of gentamycin.


paromomycin catabolic process

The chemical reactions and pathways resulting in the breakdown of paromomycin.


(-)-secologanin catabolic process

The chemical reactions and pathways resulting in the breakdown of (-)-secologanin.


The chemical reactions and pathways resulting in the breakdown of sophorosyloxydocosanoate, 13-sophorosyloxydocosanoate 6',6''-diacetate.


2-deoxyribose 1-phosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of deoxyribose 1-phosphate, the phosphorylated sugar 1-phospho-2-deoxyribose.


glucosamine-containing compound catabolic process

The chemical reactions and pathways resulting in the breakdown of glucosamine-containing compounds (glucosamines).


O-sialoglycoprotein catabolic process

The chemical reactions and pathways resulting in the breakdown of O-sialoglycoproteins, glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities.


cuticle chitin catabolic process

The chemical reactions and pathways resulting in the breakdown of cuticle chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues, found in cuticles.


The chemical reactions and pathways resulting in the breakdown of poly-N-acetyllactosamine, a carbohydrate composed of N-acetyllactosamine repeats (Gal-beta-1,4-GlcNAc-beta-1,3)n.


amylopectin catabolic process

The chemical reactions and pathways resulting in the breakdown of an amylopectin.


galactosaminoglycan catabolic process

The chemical reactions and pathways resulting in the breakdown of galactosaminoglycans, any of a group of polysaccharides that contain amino sugars derived from the galactose.


cell wall chitin catabolic process

The chemical reactions and pathways resulting in the breakdown of cell wall chitin, a linear polysaccharide consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues, found in the walls of cells.


aminoglycan catabolic process

The chemical reactions and pathways resulting in the breakdown of aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.


lincomycin catabolic process

The chemical reactions and pathways resulting in the breakdown of lincomycin.


neomycin catabolic process

The chemical reactions and pathways resulting in the breakdown of neomycin.


S-glycoside catabolic process

The chemical reactions and pathways resulting in the breakdown of S-glycosides, any compound in which a glycosyl group has been substituted into a thiol group.


D-tagatose 6-phosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a D-tagatose 6-phosphate.


ascospore wall chitin catabolic process

The chemical reactions and pathways resulting in the breakdown of ascospore wall chitin, a linear polysaccharide consisting of P-1,4-linked N-acetyl-D-glucosamine residues, found in the walls of ascospores.


lipoteichoic acid catabolic process

The chemical reactions and pathways resulting in the breakdown of lipoteichoic acid, which is a major component of the cell wall of gram-positive bacteria and typically consists of a chain of glycerol-phosphate repeating units linked to a glycolipid anchor.


kanamycin catabolic process

The chemical reactions and pathways resulting in the breakdown of kanamycin.


diacetylchitobiose catabolic process

The chemical reactions and pathways resulting in the breakdown of diacetylchitobiose into simpler products.


diacetylchitobiose catabolic process to glucosamine and acetate

The pathway resulting in the breakdown of diacetylchitobiose into simpler products, including glucosamine and glucosamine. The catabolism proceeds by the deacetylation of diacetylchitobiose, producing acetate and GlcN-GlcNAc; the latter is cleaved to produce glucosamine (GlcN) and N-acetylglucosamine (GlcNAc). The N-acetylglucosamine (GlcNAc) is then deacetylated to produce glucosamine (GlcN) and acetate.


aminoglycoside antibiotic catabolic process

The chemical reactions and pathways resulting in the breakdown of an aminoglycoside antibiotic, any member of a group of broad spectrum antibiotics, of similar toxicity and pharmacology, that contain an aminodeoxysugar, an amino- or guanidino-substituted inositol ring, and one or more residues of other sugars. The group includes streptomycin, neomycin, framycetin, kanamycin, paromomycin, and gentamicin.


ergosteryl 3-beta-D-glucoside catabolic process

The chemical reactions and pathways resulting in the breakdown of ergosteryl 3-beta-D-glucoside.


N-acetylmannosamine catabolic process

The chemical reactions and pathways resulting in the breakdown of N-acetylmannosamine, the acetylated derivative of mannosamine, 2-amino-2-deoxymannose.


glycosyl compound catabolic process

The chemical reactions and pathways resulting in the breakdown of glycosyl compound.


mannosamine catabolic process

The chemical reactions and pathways resulting in the breakdown of mannosomine, 2-amino-2-deoxymannose; the D-isomer is a constituent of neuraminic acids as well as mucolipids and mucoproteins.


mannoprotein catabolic process

The chemical reactions and pathways resulting in the breakdown of a mannoprotein, a protein that contains covalently bound mannose residues.


teichoic acid catabolic process

The chemical reactions and pathways resulting in the breakdown of teichoic acid, which is a major component of the cell wall of Gram-positive bacteria and typically consists of a polymer of glycerol-phosphate or ribitol-phosphate to which are attached glycosyl and D-alanyl ester residues.


lipooligosaccharide catabolic process

The chemical reactions and pathways resulting in the breakdown of lipooligosaccharide.


saponin catabolic process

The chemical reactions and pathways resulting in the breakdown of saponins, glycosides of plants in which the aglycan (sapogenin) group is a terpene or steroid and the sugar group is a glucose, a galactose, a pentose, a methylpentose or an oligosaccharide. Saponins are powerful surfactant agents and membrane active; they are, hence, toxic to animals on injection.


zeaxanthin bis(beta-D-glucoside) catabolic process

The chemical reactions and pathways resulting in the breakdown of zeaxanthin bis(beta-D-glucoside).


leaf papilla

biolink:CellularComponent biolink:AnatomicalEntity biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssence biolink:SubjectOfInvestigation biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

A plant cell papilla that is part of a leaf papilla cell.


U12-type post-mRNA release spliceosomal complex

A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and the U12, U5 and U6atac snRNPs.


U12-type prespliceosome

A spliceosomal complex that is formed by the cooperative binding of the heterodimeric U11/U12 snRNP to the 5' splice site and the branch point sequence. The U12-type prespliceosome includes many proteins in addition to those found in the U11/U12 heterodimeric snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation.


U12-type precatalytic spliceosome

A spliceosomal complex that is formed by the recruitment of the preassembled U4atac/U6atac.U5 tri-snRNP to the U12-type prespliceosome. Although all 5 snRNPs are present, the precatalytic spliceosome is catalytically inactive. The precatalytic spliceosome includes many proteins in addition to those found in the U11, U12 and U4atac/U6atac.U5 snRNPs.


U12-type post-spliceosomal complex

A spliceosomal complex that is formed following the second splicing event and contains the spliced product, the excised intron, and three snRNPs, U5, U12 and U6atac.


U12-type catalytic step 2 spliceosome

A spliceosomal complex that contains the U12, U5 and U6atac snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U12, U5 and U6atac snRNPs.


prespliceosome

A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Prespliceosome complexes are not active for splicing, but are instead an early step in the assembly of a spliceosomal complex.


catalytic step 1 spliceosome

A spliceosomal complex that is formed by the displacement of the two snRNPs from the precatalytic spliceosome; three snRNPs including U5 remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the associated snRNPs.


trans spliceosomal complex

A spliceosomal complex that forms during the addition of a specific spliced leader (SL) sequence to the 5'-end of a messenger RNA primary transcript, a process which occurs in a number of eukaryotic organisms, including trypanosomatid protozoans, euglenoids, nematodes, trematodes, and chordates.


U12-type catalytic step 1 spliceosome

A spliceosomal complex that is formed by the displacement of the U11 and U4atac snRNPs from the precatalytic spliceosome; the U12, U5 and U6atac snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U12, and U5 and U6atac snRNPs.


pre T-cell antigen receptor alpha

A protein that is a translation product of the human PTCRA gene or a 1:1 ortholog thereof.


pre T-cell antigen receptor alpha isoform h3 (human)

A pre T-cell antigen receptor alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISU1-3.


pre T-cell antigen receptor alpha isoform h2 (human)

A pre T-cell antigen receptor alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISU1-2.


pre T-cell antigen receptor alpha isoform h1 (human)

A pre T-cell antigen receptor alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISU1-1.


zinc finger protein 385D

A protein that is a translation product of the human ZNF385D gene or a 1:1 ortholog thereof.


SAP domain-containing ribonucleoprotein isoform 1 (human)

A nuclear protein Hcc-1 isoform 1 that is encoded in the genome of human.


ephrin-B1, signal peptide removed phosphorylated 1 (human)

An ephrin-B1 (human) that has had the signal peptide removed and has been post-translationally modified to include phosphotyrosine at positions 324, 329 and 343 of the amino acid sequence represented by UniProtKB:P98172. UniProtKB:P98172, 28-346, Tyr-324/Tyr-329/Tyr-343, MOD:00048.


ephrin-B1, signal peptide removed form (human)

An ephrin-B1 (human) that has had the signal peptide removed. UniProtKB:P98172, 28-346.


regulation of aplanospore formation

Any process that modulates the frequency, rate or extent of aplanospore formation, a process in which a nonmotile, asexual spore is formed within a cell in certain algae and fungi (commonly in the Phycomycetes), the wall of aplanospore is distinct from that of the parent cell.


positive regulation of aplanospore formation

Any process that activates, maintains or increases the frequency, rate or extent of aplanospore formation, a process in which a nonmotile, asexual spore is formed within a cell in certain algae and fungi (commonly in the Phycomycetes), the wall of aplanospore is distinct from that of the parent cell.


palmitoyltransferase ZDHHC8 isoform h3 (human)

A palmitoyltransferase ZDHHC8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC8-3.


palmitoyltransferase ZDHHC8

A protein that is a translation product of the human ZDHHC8 gene or a 1:1 ortholog thereof.


palmitoyltransferase ZDHHC8 isoform h2 (human)

A palmitoyltransferase ZDHHC8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC8-2.


palmitoyltransferase ZDHHC8 isoform h1 (human)

A palmitoyltransferase ZDHHC8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULC8-1.


heme C biosynthetic process

The chemical reactions and pathways resulting in the formation of heme c, a derivative of heme found in cytochromes c, b4, and f.


maestro heat-like repeat-containing protein family member 7 isoform h1 (human)

A maestro heat-like repeat-containing protein family member 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q68CQ1-7.


disabled homolog 2-interacting protein isoform 1 (human)

A disabled homolog 2-interacting protein isoform 1 that is encoded in the genome of human.


disabled homolog 2-interacting protein isoform 5 (human)

A disabled homolog 2-interacting protein isoform 5 that is encoded in the genome of human.


disabled homolog 2-interacting protein isoform h4 (human)

A disabled homolog 2-interacting protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VWQ8-4.


disabled homolog 2-interacting protein isoform h2 (human)

A disabled homolog 2-interacting protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VWQ8-2.


disabled homolog 2-interacting protein isoform h3 (human)

A disabled homolog 2-interacting protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VWQ8-3.


erbin isoform h1 (human)

An erbin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96RT1-1.


maltose transporting porin activity

Enables the transfer of maltose from one side of a membrane to the other. Maltose is the disaccharide 4-O-alpha-D-glucopyranosyl-D-glucopyranose, an intermediate in the enzymatic breakdown of glycogen and starch. This transporter is a porin so enables the energy independent passage of substances, sized less than 1000 Da, across a membrane. The transmembrane portions of porins consist exclusively of beta-strands which form a beta-barrel. They are found in the outer membranes of Gram-negative bacteria, mitochondria, plastids and possibly acid-fast Gram-positive bacteria.


transmembrane emp24 domain-containing protein 10 isoform 1 (human)

A transmembrane emp24 domain-containing protein 10 isoform 1 that is encoded in the genome of human.


serine/threonine-protein kinase Nek9, initiator methionine removed phosphorylated 3 (human)

A serine/threonine-protein kinase Nek9 (human) that has had the initiator methionine removed and has been post-translationally modified to include phosphoserine at positions 29, 750 and 869, and phosphothreonine at position 333 of the amino acid sequence represented by UniProtKB:Q8TD19. UniProtKB:Q8TD19, 2-979, Ser-29/Ser-750/Ser-869, MOD:00046|Thr-333, MOD:00047.


regulator of G-protein signaling 7 isoform 2 (human)

A regulator of G-protein signaling 7 isoform 2 that is encoded in the genome of human.


regulation of telomeric loop disassembly

Any process that modulates the frequency, rate or extent of telomeric loop disassembly.


positive regulation of telomeric D-loop disassembly

Any process that activates or increases the frequency, rate or extent of telomeric D-loop disassembly.


regulation of telomeric D-loop disassembly

Any process that modulates the frequency, rate or extent of telomeric D-loop disassembly.


calsyntenin-3 isoform 1 (human)

A calsyntenin-3 isoform 1 that is encoded in the genome of human.


interferon regulatory factor 5 isoform h5 (human)

An interferon regulatory factor 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13568-5.


eukaryotic translation initiation factor 2 subunit 3 isoform 1 (human)

A eukaryotic translation initiation factor 2 subunit 3, X-linked isoform 1 that is encoded in the genome of human.


voltage-dependent L-type calcium channel subunit beta-1 isoform h2 (human)

A voltage-dependent L-type calcium channel subunit beta-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q02641-2.


voltage-dependent L-type calcium channel subunit beta-1 isoform h3 (human)

A voltage-dependent L-type calcium channel subunit beta-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q02641-3.


voltage-dependent L-type calcium channel subunit beta-1 isoform h1 (human)

A voltage-dependent L-type calcium channel subunit beta-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q02641-1.


histone H3.3, initiator methionine removed acetylated 8 (human)

A histone H3.3 (human) that has had the initiator methionine removed and that has been acetylated at the position equivalent to Lys-15 of the amino acid sequence represented by UniProtKB:P84243. UniProtKB:P84243, 2-136, Lys-15, MOD:00064.


neuroguidin isoform h1 (human)

A neuroguidin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NEJ9-1.


neuroguidin isoform h2 (human)

A neuroguidin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NEJ9-2.


LIM and senescent cell antigen-like-containing domain protein 3 isoform h1 (human)

A LIM and senescent cell antigen-like-containing domain protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P0CW19-1.


40S ribosomal protein S23 isoform 1 (human)

A 40S ribosomal protein S23 isoform 1 that is encoded in the genome of human.


40S ribosomal protein S23, initiator methionine removed form (human)

A 40S ribosomal protein S23 (human) that has had the initiator methionine removed. UniProtKB:P62266, 2-143.


positive regulation of pheromone response MAPK cascade

Any process that activates or increases the frequency, rate or extent of a pheromone response MAPK cascade.


positive regulation of cell wall integrity MAPK cascade

Any process that activates or increases the frequency, rate or extent of MAPK cascade involved in cell wall organization or biogenesis.


tRNA A64-2'-O-ribosylphosphate transferase activity

Catalysis of the transfer of a phosphoribosyl group from 5'-phosphoribosyl-1'-pyrophosphate to position 64 of initiator tRNA.


plasma membrane proton-transporting V-type ATPase, V0 domain

The V0 domain of a proton-transporting V-type ATPase found in the plasma membrane.


lysosomal proton-transporting V-type ATPase, V0 domain

The V0 domain of a proton-transporting V-type ATPase found in the lysosomal membrane.


inactive serine/threonine-protein kinase VRK3

A protein that is a translation product of the human VRK3 gene or a 1:1 ortholog thereof.


inactive serine/threonine-protein kinase VRK3 isoform h2 (human)

An inactive serine/threonine-protein kinase VRK3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IV63-2.


inactive serine/threonine-protein kinase VRK3 isoform h1 (human)

An inactive serine/threonine-protein kinase VRK3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IV63-1.


inactive serine/threonine-protein kinase VRK3 isoform h3 (human)

An inactive serine/threonine-protein kinase VRK3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IV63-3.


zinc finger CCCH domain-containing protein 14 isoform h8 (human)

A zinc finger CCCH domain-containing protein 14 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6PJT7-8.


chorionic trophoblast cell proliferation

The multiplication or reproduction of chorionic trophoblast cells, resulting in the expansion of their population.


mycothiol biosynthetic process

The chemical reactions and pathways resulting in the formation of mycothiol, which consists of N-acetyl-L-cysteine linked to a pseudodisaccharide, D-glucosamine and myo-inositol. Mycothiol is produced in actinomycetes like mycobacteria and serves similar functions to glutathione.


sphingomyelin phosphodiesterase 4 isoform h2 (human)

A sphingomyelin phosphodiesterase 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NXE4-2.


OTU domain-containing protein 5 isoform h4 (human)

An OTU domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96G74-4.


deoxyuridine biosynthetic process

The chemical reactions and pathways resulting in the formation of deoxyuridine, 2-deoxyribosyluracil, one of the four major nucleosides of DNA.


protein kinase C alpha type, initiator methionine removed phosphorylated 1 (human)

A protein kinase C alpha type (human) that has had the initiator methionine removed and has been post-translationally modified to include phosphothreonine at position 497 of the amino acid sequence represented by UniProtKB:P17252. UniProtKB:P17252, 2-672, Thr-497, MOD:00047.


ETS domain-containing protein Elk-4 isoform h2 (human)

An ETS domain-containing protein Elk-4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28324-2.


ETS domain-containing protein Elk-4 O-glycosylated 1 (human)

An ETS domain-containing protein Elk-4 (human) that has been O-glycosylated at the residue equivalent to Ser-235 of the amino acid sequence represented by UniProtKB:P28324-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P28324-1, Ser-235, MOD:00002~GNO:G58001LT.


ETS domain-containing protein Elk-4 isoform h1 (human)

An ETS domain-containing protein Elk-4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28324-1.


hematopoietic prostaglandin D synthase, initiator methionine removed form (human)

A hematopoietic prostaglandin D synthase (human) that has had the initiator methionine removed. UniProtKB:O60760, 2-199.


centrosomal protein of 135 kDa isoform h2 (human)

A centrosomal protein of 135 kDa (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q66GS9-2.


serum paraoxonase/arylesterase 2

A protein that is a translation product of the human PON2 gene or a 1:1 ortholog thereof.


serum paraoxonase/arylesterase 2 isoform 1 (human)

A serum paraoxonase/arylesterase 2 isoform 1 that is encoded in the genome of human.


serum paraoxonase/arylesterase 2 isoform h3 (human)

A serum paraoxonase/arylesterase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15165-3.


serum paraoxonase/arylesterase 2 isoform h2 (human)

A serum paraoxonase/arylesterase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15165-2.


fractalkine, signal peptide removed form (human)

A fractalkine (human) that has had the signal peptide removed. UniProtKB:P78423, 25-397.


E3 ubiquitin-protein ligase TRIM7 isoform h4 (human)

An E3 ubiquitin-protein ligase TRIM7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9C029-1.


cardiolipin synthase (CMP-forming) isoform h1 (human)

A cardiolipin synthase (CMP-forming) (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJA2-1.


CMP-forming cardiolipin synthase

A protein that is a translation product of the human CRLS1 gene or a 1:1 ortholog thereof.


cardiolipin synthase (CMP-forming) isoform h2 (human)

A cardiolipin synthase (CMP-forming) (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJA2-2.


alpha-endosulfine isoform 1 (human)

An alpha-endosulfine isoform 1 that is encoded in the genome of human.


1,1,2-trichloroethene reductive dehalogenase activity

Catalysis of the reaction: trichloroethene + 2 H+ + 2 e- = HCl + 1,2-dichloroethene.


Catalysis of the reaction: L-proline + NAD(P)+ = 1-pyrroline-2-carboxylate + NAD(P)H + H+.


A protein that is a translation product of the human UPK3A gene or a 1:1 ortholog thereof.


uroplakin-3a isoform 1 (human)

A uroplakin-3a isoform 1 that is encoded in the genome of human.


uroplakin-3a isoform h2 (human)

A uroplakin-3a (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75631-2.


abscission/NoCut checkpoint regulator isoform h3 (human)

An abscission/NoCut checkpoint regulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96K21-3.


abscission/NoCut checkpoint regulator isoform h2 (human)

An abscission/NoCut checkpoint regulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96K21-2.


abscission/NoCut checkpoint regulator isoform h1 (human)

An abscission/NoCut checkpoint regulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96K21-1.


abscission/NoCut checkpoint regulator isoform h4 (human)

An abscission/NoCut checkpoint regulator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96K21-4.


homeodomain-interacting protein kinase 2 isoform h1 (human)

A homeodomain-interacting protein kinase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2X6-1.


homeodomain-interacting protein kinase 2

A protein that is a translation product of the human HIPK2 gene or a 1:1 ortholog thereof.


homeodomain-interacting protein kinase 2 isoform h2 (human)

A homeodomain-interacting protein kinase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2X6-2.


homeodomain-interacting protein kinase 2 isoform h3 (human)

A homeodomain-interacting protein kinase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2X6-3.


homeodomain-interacting protein kinase 2 phosphorylated form (human)

A homeodomain-interacting protein kinase 2 (human) that includes at least one phosphorylated residue. UniProtKB:Q9H2X6, MOD:00696.


lateral motor column neuron differentiation

The process in which differentiating motor neurons in the neural tube acquire the specialized structural and/or functional features of lateral motor column neurons. Lateral motor column neurons are generated only on limb levels and send axons into the limb mesenchyme. Differentiation includes the processes involved in commitment of a cell to a specific fate.


pre-mRNA-splicing factor SYF1 isoform 1 (human)

A pre-mRNA-splicing factor SYF1 isoform 1 that is encoded in the genome of human.


pre-mRNA-splicing factor SYF1

A protein that is a translation product of the human XAB2 gene or a 1:1 ortholog thereof.


gamma-aminobutyric acid receptor-associated protein-like 1 isoform 1 (human)

A gamma-aminobutyric acid receptor-associated protein-like 1 isoform 1 that is encoded in the genome of human.


CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase isoform hD2+26 (human)

A CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q11203-23.


E3 ubiquitin-protein ligase MGRN1 isoform h2 (human)

An E3 ubiquitin-protein ligase MGRN1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60291-2.


amiloride-sensitive sodium channel subunit delta isoform h3 (human)

An amiloride-sensitive sodium channel subunit delta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51172-3.


amiloride-sensitive sodium channel subunit delta

An epithelial sodium channel protein that is a translation product of the human SCNN1D gene or a 1:1 ortholog thereof.


amiloride-sensitive sodium channel subunit delta isoform h1 (human)

An amiloride-sensitive sodium channel subunit delta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51172-1.


amiloride-sensitive sodium channel subunit delta isoform h2 (human)

An amiloride-sensitive sodium channel subunit delta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51172-2.


Catalysis of the reaction: isorhamnetin + S-adenosyl-L-methionine <=> 3,3'-dimethylquercetin + S-adenosyl-L-homocysteine.


titin isoform h2 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-2.


titin

A protein that is a translation product of the human TTN gene or a 1:1 ortholog thereof.


titin isoform h8 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-8.


titin isoform h6 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-6.


titin isoform h3 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-3.


titin isoform h11 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-11.


titin isoform h13 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-13.


titin isoform h9 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-9.


titin isoform h12 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-12.


titin isoform h4 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-4.


titin isoform h1 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-1.


titin isoform h5 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-5.


titin isoform h7 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-7.


titin isoform h10 (human)

A titin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WZ42-10.


protein OS-9 isoform h7 (human)

A protein OS-9 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13438-7.


succinate-semialdehyde dehydrogenase, mitochondrial isoform h1 (human)

A succinate-semialdehyde dehydrogenase, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51649-1.


oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor

Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH2 group acts as a hydrogen or electron donor and reduces a disulfide group.


immunoglobulin heavy constant mu N-glycosylated 111 (human)

An immunoglobulin heavy constant mu (human) that has been N-glycosylated at the residue equivalent to Asn-46 of the amino acid sequence represented by UniProtKB:P01871-1, in which the glycan composition is represented by GlyTouCan:G44953PJ. Example: UniProtKB:P01871-1, Asn-46, MOD:00160~GNO:G44953PJ.


MAP7 domain-containing protein 1 isoform h3 (human)

A MAP7 domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3KQU3-3.


fatty acid-binding protein 5 isoform 1 (human)

A fatty acid-binding protein 5 isoform 1 that is encoded in the genome of human.


fatty acid-binding protein 5, initiator methionine removed form (human)

A fatty acid-binding protein 5 (human) that has had the initiator methionine removed. UniProtKB:Q01469, 2-135.


zinc finger protein 641 isoform h2 (human)

A zinc finger protein 641 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96N77-2.


polypeptide N-acetylgalactosaminyltransferase 2 isoform h1 (human)

A polypeptide N-acetylgalactosaminyltransferase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q10471-1.


polypeptide N-acetylgalactosaminyltransferase 2 O-glycosylated 1 (human)

A polypeptide N-acetylgalactosaminyltransferase 2 (human) that has been O-glycosylated at the residue equivalent to Thr-368 of the amino acid sequence represented by UniProtKB:Q10471-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q10471-1, Thr-368, MOD:00005~GNO:G43417UB.


polypeptide N-acetylgalactosaminyltransferase 2 isoform h2 (human)

A polypeptide N-acetylgalactosaminyltransferase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q10471-2.


cardioblast migration to the midline involved in heart rudiment formation

The orderly movement of a cardioblast toward the midline that contributes to the initial appearance of the heart rudiment.


synaptophysin-like protein 2 isoform h1 (human)

A synaptophysin-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VXT5-1.


negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.


negative regulation of planar cell polarity pathway involved in heart morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.


negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.


negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.


negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.


negative regulation of planar cell polarity pathway involved in pericardium morphogenesis

Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.


synaptic vesicle tethering involved in synaptic vesicle exocytosis

The initial, indirect interaction between a synaptic vesicle membrane and a the preseynaptic membrane active zone. This interaction is mediated by tethering factors (or complexes), which interact with both membranes. This process is distinct from and prior to synaptic vesicle priming and fusion.


P2Y5 nucleotide receptor binding

Binding to a P2Y5 nucleotide receptor.


homeobox protein MIXL1 isoform h2 (human)

A homeobox protein MIXL1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2W2-2.


N-alpha-acetyltransferase 15, NatA auxiliary subunit

A protein that is a translation product of the human NAA15 gene or a 1:1 ortholog thereof.


N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h2 (human)

An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-4.


N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h1 (human)

An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-1.


bacterial-type flagellum rotor complex

The rotor complex of the bacterial-type flagellum consists of a membrane-anchored ring and the motor switch complex, which participates in the conversion of proton/Na+ energy into the mechanical work of rotation and controls the direction of flagellar rotation.


formamide biosynthetic process

The chemical reactions and pathways resulting in the formation of formamide, the simplest amide, HCONH2, derived from formic acid.


anaphase-promoting complex subunit 2 isoform h1 (human)

An anaphase-promoting complex subunit 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJX6-1.


F-box only protein 10 isoform h1 (human)

An F-box only protein 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UK96-1.


D-tagatose 6-phosphate metabolic process

The chemical reactions and pathways involving a D-tagatose 6-phosphate.


peptidyl-(Z)-dehydrobutyrine biosynthetic process from peptidyl-threonine

The formation of (Z)-dehydrobutyrine by the dehydration of peptidyl-threonine.


ubiquitin-conjugating enzyme E2 G2

A protein that is a translation product of the human UBE2G2 gene or a 1:1 ortholog thereof.


ubiquitin-conjugating enzyme E2 G2 isoform h2 (human)

A ubiquitin-conjugating enzyme E2 G2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60604-2.


ubiquitin-conjugating enzyme E2 G2 isoform 1 (human)

A ubiquitin-conjugating enzyme E2 G2 isoform 1 that is encoded in the genome of human.


lateral mesoderm morphogenesis

The process in which the anatomical structures of the lateral mesoderm are generated and organized.


mitochondrial tricarboxylic acid cycle enzyme complex

Any of the heteromeric enzymes, located in the mitochondrion, that act in the tricarboxylic acid (TCA) cycle.


heterogeneous nuclear ribonucleoprotein U, initiator methionine removed form (human)

A heterogeneous nuclear ribonucleoprotein U (human) that has had the initiator methionine removed. UniProtKB:Q00839, 2-825.


Catalysis of the reaction: 4alpha-hydroxymethyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + NADH + O2 + H+ <=> 4alpha-formyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(241)-en-3beta-ol + NAD + 2 H2O.


regulation of nucleotide biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nucleotides.


regulation of cellular metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.


positive regulation of mating-type specific transcription, DNA-templated

Any mating-type specific process that activates or increases the rate of cellular DNA-templated transcription.


regulation of inositol phosphate biosynthetic process

Any process that modulates the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.


regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA

Any process that modulates the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.


regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts

Any process that modulates the rate, frequency, or extent of selective degradation of meiosis-specific nuclear transcribed transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.


regulation of phosphatidylglycerol biosynthetic process

Any process that modulates the frequency, rate or extent of phosphatidylglycerol biosynthetic process.


regulation of ncRNA transcription

Any process that modulates the frequency, rate or extent of transcription of a non-protein coding gene from a DNA-template.


regulation of tatiopterin biosynthetic process

Any process that modulates the frequency, rate or extent of tatiopterin biosynthetic process.


regulation of selenocysteine metabolic process

Any process that modulates the frequency, rate or extent of selenocysteine metabolic process.


regulation of nonadec-1-ene metabolic process

Any process that modulates the frequency, rate or extent of nonadec-1-ene metabolic process.


regulation of ethylene biosynthetic process

Any process that modulates the frequency, rate, or extent of an ethylene biosynthetic process.


negative regulation of methyl-branched fatty acid biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of methyl-branched fatty acid biosynthetic process.


regulation of reticulophagy

Any process that modulates the frequency, rate or extent of reticulophagy.


negative regulation of tetrapyrrole metabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole metabolic process.


regulation of antibacterial peptide secretion

Any process that modulates the frequency, rate, or extent of antibacterial peptide secretion.


regulation of cutin biosynthetic process

Any process that modulates the frequency, rate or extent of cutin biosynthetic process.


positive regulation of purine nucleotide catabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.


regulation of antifungal peptide secretion

Any process that modulates the frequency, rate, or extent of antifungal peptide secretion.


negative regulation of toluene metabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of toluene metabolic process.


negative regulation of carotenoid biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of carotenoid biosynthetic process.


regulation of dosage compensation by inactivation of X chromosome

Any process that modulates the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.


regulation of transforming growth factor beta3 production

Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta3.


positive regulation of vitamin E biosynthetic process

Any process that activates or increases the frequency, rate or extent of vitamin E biosynthetic process.


positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle

Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as part of the meiotic cell cycle.


negative regulation of macrophage colony-stimulating factor production

Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor production.


regulation of cell wall (1->3)-beta-D-glucan biosynthetic process

Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of cells.


suppression by virus of host gene expression

Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of gene expression in the host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.


programmed DNA elimination by elimination of internal DNA segments

A programmed DNA elimination mechanism in which specific sequences, namely, internal eliminated sequences (IES) and breakage eliminated sequences (BES) are removed from the genome. This process is known to occur in ciliates.


negative regulation of interleukin-37 production

Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-37 production.


transitive RNA interference

An RNA interference where the silencing signal spreads along the target mRNA in a 5' or 3' direction, outside of the initial target sequence.


epigenetic programming in the central cell

The establishment of epigenetic modifications (imprints) in a plant central cell, leading to an asymmetry between the two maternal alleles and the paternal allele, and differential expression of the corresponding alleles in the developing endosperm. This can happen through heterochromatin formation or differential chromatin loop formation.


positive regulation of pyrimidine nucleobase metabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving pyrimidine nucleobases.


regulation of aggrephagy

Any process that modulates the frequency, rate or extent of aggrephagy.


positive regulation of methane biosynthetic process from trimethylamine

Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from trimethylamine.


regulation of (R)-mevalonic acid biosynthetic process

Any process that modulates the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


nitrogen catabolite regulation of transcription

A transcription regulation process in which the presence of one nitrogen source leads to the modulation of the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other nitrogen sources.


positive regulation of tetrapyrrole biosynthetic process

Any process that activates or increases the frequency, rate or extent of tetrapyrrole biosynthetic process.


positive regulation of phospholipid metabolic process

Any process that activates or increases the frequency, rate or extent of phospholipid metabolic process.


regulation of ent-pimara-8(14),15-diene biosynthetic process

Any process that modulates the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


negative regulation of methanophenazine metabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of methanophenazine metabolic process.


regulation of siRNA-dependent facultative heterochromatin formation

Any process that modulates the frequency, rate or extent of siRNA-dependent facultative heterochromatin formation.


positive regulation of transcription from a mobile element promoter

Any process that activates or increases the frequency, rate or extent of transcription from a mobile element promoter.


negative regulation of interleukin-26 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-26 production.


positive regulation of chlorophyll catabolic process

Any process that activates or increases the frequency, rate or extent of chlorophyll catabolic process.


negative regulation of (+)-kotanin biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of (+)-kotanin biosynthetic process.


regulation of interleukin-34 production

Any process that modulates the frequency, rate or extent of interleukin-34 production.


regulation of error-prone translesion synthesis

Any process that modulates the frequency, rate or extent of error-prone translesion synthesis.


regulation of transcription by galactose

Any process involving galactose that modulates the frequency, rate or extent or transcription.


siRNA-mediated facultative heterochromatin formation

The formation of facultative heterochromatin into a heterochromatin domain, enriched in histone H3 methylated on lysine 9 (H3K9me), by a process mediated by a small interfering RNA.


positive regulation of heptadecane biosynthetic process

Any process that activates or increases the frequency, rate or extent of heptadecane biosynthetic process.


regulation of cyclic nucleotide catabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of cyclic nucleotides.


negative regulation of violaceol II biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of violaceol II biosynthetic process.


regulation of violaceol I biosynthetic process

Any process that modulates the frequency, rate or extent of violaceol I biosynthetic process.


regulation of cellular catabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.


positive regulation of (1->3)-beta-D-glucan biosynthetic process

Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


negative regulation of chemokine (C-X-C motif) ligand 1 production

Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.


nitrogen catabolite activation of transcription

A transcription regulation process in which the presence of one nitrogen source leads to an increase in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other nitrogen sources.


regulation of pteridine metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving pteridine.


regulation of granulocyte colony-stimulating factor production

Any process that modulates the frequency, rate, or extent of production of granulocyte colony-stimulating factor.


tRNA destabilization

Any process that decreases the stability of a tRNA molecule, making it more vulnerable to degradative processes.


regulation of methanophenazine metabolic process

Any process that modulates the frequency, rate or extent of methanophenazine metabolic process.


induction by virus of host autophagy

Any process in which a virus activates or increases the frequency, rate or extent of autophagy in the host.


positive regulation of tatiopterin biosynthetic process

Any process that activates or increases the frequency, rate or extent of tatiopterin biosynthetic process.


regulation of pentadecane biosynthetic process

Any process that modulates the frequency, rate or extent of pentadecane biosynthetic process.


positive regulation of antisense RNA transcription

Any process that increases the frequency, rate or extent of the synthesis of antisense RNA, an RNA molecule complementary in sequence to another RNA or DNA molecule, which, by binding the latter, acts to inhibit its function and/or completion of synthesis, on a template of DNA.


regulation of mitochondrial ATP synthesis coupled electron transport

Any process that modulates the frequency, rate or extent of mitochondrial ATP synthesis coupled electron transport.


positive regulation of glycolytic process through fructose-6-phosphate

Any process that activates or increases the frequency, rate or extent of glycolytic process through fructose-6-phosphate.


regulation of interleukin-15 production

Any process that modulates the frequency, rate, or extent of interleukin-15 production.


silent mating-type cassette heterochromatin formation

Repression of transcription at silent mating-type loci by alteration of the structure of chromatin.


negative regulation of bile acid metabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of bile acid metabolic process.


regulation of RNA polymerase III activity

Any process that modulates the frequency, rate or extent of RNA polymerase III activity.


regulation of regulatory ncRNA-mediated heterochromatin formation

Any process that modulates the frequency, rate or extent of small non-coding RNA-mediated heterochromatin formation.


regulation of phenazine biosynthetic process

Any process that modulates the frequency, rate or extent of phenazine biosynthetic process.


regulation of type III site-specific deoxyribonuclease activity

Any process that modulates the frequency, rate or extent of a type III restriction endodeoxyribonuclease activity.


regulation of vitamin A metabolic process

Any process that modulates the frequency, rate or extent of vitamin A metabolic process.


negative regulation of pentadecane biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of pentadecane biosynthetic process.


regulation of amylopectin catabolic process

Any process that modulates the frequency, rate or extent of amylopectin catabolic process.


positive regulation of antimicrobial peptide secretion

Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide secretion.


negative regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA

Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.


positive regulation of juvenile hormone catabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of juvenile hormone.


regulation of interleukin-11 production

Any process that modulates the frequency, rate, or extent of interleukin-11 production.


negative regulation of interleukin-34 production

Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-34 production.


regulation of pectin biosynthetic process

Any process that modulates the frequency, rate or extent of pectin biosynthetic process.


regulation of hexadecanal metabolic process

Any process that modulates the frequency, rate or extent of hexadecanal metabolic process.


positive regulation of phosphatidylglycerol biosynthetic process

Any process that activates or increases the frequency, rate or extent of phosphatidylglycerol biosynthetic process.


negative regulation of cellular metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.


regulation of interleukin-33 production

Any process that modulates the frequency, rate or extent of interleukin-33 production.


regulation of chemokine (C-C motif) ligand 4 production

Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 4.


regulation of interleukin-37 production

Any process that modulates the frequency, rate or extent of interleukin-37 production.


negative regulation of syringal lignin catabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of syringal lignin catabolic process.


negative regulation of interleukin-16 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production.


positive regulation of pentadecane metabolic process

Any process that activates or increases the frequency, rate or extent of pentadecane metabolic process.


regulation of 4,6-pyruvylated galactose residue biosynthetic process

Any process that modulates the rate, frequency, or extent of 4,6-pyruvylated galactose residue biosynthetic process, the chemical reactions and pathways resulting in the formation of the pyruvylated galactose residue 4-6-O-[(R)(1-carboxyethylidine)]-Gal-beta-(1->3)-. The galactose residue is part of a larger polysaccharide chain.


positive regulation of ergosterol biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ergosterol.


regulation of cellular organofluorine metabolic process

Any process that modulates the rate, frequency or extent of the chemical reactions and pathways involving organofluorine compounds, as carried out by individual cells.


negative regulation of cardiolipin metabolic process

Any process that stops, prevents or reduces the frequency, rate or extent of cardiolipin metabolic process.


regulation of cell wall chitin biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cell wall chitin.


positive regulation of bile acid metabolic process

Any process that activates or increases the frequency, rate or extent of bile acid metabolic process.


regulation of pyrimidine nucleotide biosynthetic process

Any process that modulates the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.


regulation of double-strand break repair via break-induced replication

Any process that modulates the frequency, rate or extent of double-strand break repair via break-induced replication.


positive regulation of interleukin-7 production

Any process that activates or increases the frequency, rate, or extent of interleukin-7 production.


negative regulation of interleukin-20 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-20 production.


negative regulation of interleukin-24 production

Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-24 production.


regulation of xenophagy

Any process that modulates the frequency, rate or extent of xenophagy.


negative regulation of glycogen metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving glycogen.


regulation of phosphatidic acid biosynthetic process

Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.


negative regulation of phosphatidylinositol 3-kinase activity

Any process that stops, prevents, or reduces the frequency, rate or extent of phosphatidylinositol 3-kinase activity.


programmed DNA elimination

A process in which genomic fragments or entire chromosomes are eliminated from somatic cells or from micronuclei of ciliates. This process occurs in the developing macronucleus (anlage) of a ciliate, as well as in other species, including vertebrates and is an irreversible mechanism of gene silencing.


positive regulation of post-transcriptional gene silencing by RNA

Any process that activates or increases the frequency, rate or extent of post-transcriptional gene silencing by RNA.


negative regulation of sarcinapterin biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin biosynthetic process.


regulation of MHC class II biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.


regulation of sarcinapterin biosynthetic process

Any process that modulates the frequency, rate or extent of sarcinapterin biosynthetic process.


negative regulation of cytochrome-c oxidase activity

Any process that stops, prevents or reduces the frequency, rate or extent of cytochrome-c oxidase activity.


regulation of lignin biosynthetic process

Any process that modulates the frequency, rate or extent of lignin biosynthetic process.


regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process

Any process that modulates the frequency, rate or extent of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process.


positive regulation of amylopectin metabolic process

Any process that activates or increases the frequency, rate or extent of amylopectin metabolic process.


positive regulation of mRNA metabolic process

Any process that activates or increases the frequency, rate or extent of mRNA metabolic process.


regulation of alkaline phosphatase activity

Any process that modulates the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.


regulation of toluene catabolic process

Any process that modulates the frequency, rate or extent of toluene catabolic process.


regulation of antimicrobial peptide secretion

Any process that modulates the frequency, rate, or extent of antimicrobial peptide secretion.


negative regulation of granzyme A production

Any process that stops, prevents or reduces the frequency, rate or extent of granzyme A production.


positive regulation of serotonin biosynthetic process

Any process that activates or increases the frequency, rate or extent of serotonin biosynthetic process.


negative regulation of methane biosynthetic process from trimethylamine

Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from trimethylamine.


regulation of tridecane biosynthetic process

Any process that modulates the frequency, rate or extent of tridecane biosynthetic process.


negative regulation of beta 2 integrin biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of beta 2 integrins.


negative regulation of diacylglycerol kinase activity

Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.


regulation of [2Fe-2S] cluster assembly

Any process that modulates the frequency, rate or extent of [2Fe-2S] cluster assembly.


regulation of juvenile hormone metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving juvenile hormone.


regulation of transforming growth factor beta production

Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta.


negative regulation of reductive pentose-phosphate cycle

Any process that stops, prevents, or reduces the frequency, rate or extent of the reductive pentose-phosphate cycle.


regulation of protection from non-homologous end joining at telomere

Any process that modulates the frequency, rate or extent of protection from non-homologous end joining at telomere.


negative regulation of cutin biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of cutin biosynthetic process.


negative regulation of phosphorus metabolic process

Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving phosphorus or compounds containing phosphorus.


positive regulation of isoprene metabolic process

Any process that activates or increases the frequency, rate or extent of isoprene metabolic process.


positive regulation of citrulline biosynthetic process

Any process that activates or increases the frequency, rate or extent of citrulline biosynthetic process.


negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity

Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity.


positive regulation of methane biosynthetic process from dimethyl sulfide

Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.


negative regulation of transforming growth factor beta3 activation

Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta3 activation.


regulation of sinapate ester biosynthetic process

Any process that modulates the frequency, rate or extent of sinapate ester biosynthesis.


regulation of phosphate metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


regulation of mitotic DNA replication initiation

Any process that modulates the frequency, rate or extent of DNA replication initiation involved in mitotic DNA replication.


negative regulation of melanization defense response

Any process that reduces the rate or extent of the melanization defense response. This regulation is critical to limit melanization to the site of injury or infection.


regulation of t-circle formation

Any process that modulates the frequency, rate or extent of t-circle formation.


positive regulation of selenocysteine metabolic process

Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.


positive regulation of interleukin-24 production

Any process that activates or increases the frequency, rate, or extent of interleukin-24 production.


positive regulation of regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process

Any process that activates or increases the frequency, rate or extent of ascospore wall (1->3)-beta-D-glucan biosynthetic process.


regulation of siRNA-independent facultative heterochromatin formation

Any process that modulates the frequency, rate or extent of siRNA-independent facultative heterochromatin assembly.


regulation of methanophenazine biosynthetic process

Any process that modulates the frequency, rate or extent of methanophenazine biosynthetic process.


negative regulation of glycolytic fermentation to ethanol

Any process that stops, prevents or reduces the frequency, rate or extent of glucose catabolic process to ethanol.


regulation of telomere maintenance in response to DNA damage

Any process that modulates the frequency, rate or extent of telomere maintenance in response to DNA damage.


negative regulation of mitochondrial ATP synthesis coupled electron transport

Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial ATP synthesis coupled electron transport.


negative regulation of lysine biosynthetic process via aminoadipic acid

Any process that stops, prevents or reduces the frequency, rate or extent of lysine biosynthetic process via aminoadipic acid.


epigenetic programming in the endosperm

The global programming of epigenetic modifications following binucleate central cell fertilization. This involves DNA methylation at the silent allele. In the endosperm, maternal genomes are hypomethylated compared with the paternal genome.


regulation of mitotic recombination-dependent replication fork processing

Any process that modulates the frequency, rate or extent of mitotic recombination-dependent replication fork processing. Regulation of mitotic recombination prevents recombination between inappropriate homologous sequences.


regulation of rDNA heterochromatin formation

Any process that modulates the rate, frequency, or extent of rDNA heterochromatin formation.


regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway

Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.